Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Condition:   Glioblastoma Interventions:   Radiation: Re-irradiation (RT);   Drug: Bevacizumab;   Drug: Nivolumab;   Procedure: Re-resection Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials